Protalix BioTherapeutics uses a plant-cell approach with ProCellEx. This has given it two approved ERTs plus PRX-115 and PRX-119. Its main focus is on a growing rare-disease pipeline. The main value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback